Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Discover the latest content that has just been published on Research Tree
Following the management overhaul in June 2023, Dolfines has undergone a big restructuring to cut costs and overcome operational issues. The governance problems led to a 50% decline in Dolfines’ turnover while the other group companies delivered flat performances. Despite cancelled contracts in H1, the company has also signed new ones to support turnover over the next year. The cash position and debt level remain an issue of vital importance despite the improving operational strength.
Companies: Dolfines SA
AlphaValue
More dilution on the horizon to solve the cash problem TARGET CHANGE CHANGE IN TARGET PRICE € 0.00 vs 0.00 -61.8% The target price resets 62% lower having been negatively impacted by the massive dilution now accounted for in our model. We have increased the number of shares to 9.6 billion from 2.96 billion to reflect the dilutive repercussions of the equity funding the company needs and will have to carry out to prop up the balance sheet and solve the cash problem to be able to finance
Immeasurable dilution smashes valuation, once more TARGET CHANGE CHANGE IN TARGET PRICE € 0.00 vs 0.01 -65.8% In the aftermath of our latest update 2 weeks ago, Dolfines has completed another round of share issuance with 1.9bn new shares. While there have been no changes to our financial estimates given no new updates on the business front, the dilution has slashed the valuation and massively weighed on the target price. CHANGE IN NAV € 0.01 vs 0.03 -65.1% Given the significant n
Business growth embarked, but dilution kills the valuation TARGET CHANGE CHANGE IN EPS 2023 : € 0.00 vs 0.00 ns 2024 : € 0.00 vs 0.00 ns Our FY22 figures have been decreased with the integration of the annual results as the net attributable result was negatively impacted by exceptional financial expenses. CHANGE IN NAV € 0.03 vs 0.10 -71.5% Similarly, share dilution has reduced the NAV valuation by more than 70% despite a slight increase in the absolute net value of the assets t
After a long period of searching for another profitable acquisition, Dolfines decided to expand its footprint in the Health, Safety and Environment market and buy out AEGIDE International, which has more than 200 clients across the world. In FY22, the acquired company generated turnover of €2.75m, and had averaged 15% annual growth over the last three years. In our view, the acquisition enhances Dolfines’ opportunities and sheds some light on the future path of the company.
Dolfines has executed an equity financing programme to prop up its balance sheet and finance an acquisition in FY22. The result was a year-long downhill trend on the share price at a stupefying level of 98%. Committed to the strategy to generate more revenues and expand market share, Dolfines embarked on another cash-accretive acquisition opportunity this year, again with equity line financing that will sustain downward pressure on the stock for at least until the end of Q1.
TARGET CHANGE CHANGE IN TARGET PRICE € 0.06 vs 0.07 -21.6% The target price is reduced due to the declining DCF and NAV values. At such low prices, a slight change in the price brings about significant change. CHANGE IN NAV € 0.10 vs 0.14 -27.4% The NAV decrease stems from the massive dilution the company carried out in FY2022 with the number of shares increasing by more than 12x. The share issuance continued in early FY2023, further reducing the NAV. CHANGE IN DCF € 0.09 vs 0.12
Capital increase slashes the valuation TARGET CHANGE CHANGE IN NAV € 0.14 vs 0.27 -48.4% Since our last update, Dolfines has continued its capital increase programme with the conversion of the remaining bonds. The conversion of notes resulted in a massive dilution by creating more than 100 million shares (almost doubling), which was reflected in the tanking share price since September 2022. Accordingly, our NAV is severely impacted by the rising number of shares. CHANGE IN DCF € 0.12
Costly financing cuts the target price TARGET CHANGE CHANGE IN TARGET PRICE € 0.14 vs 0.40 -66.0% In the aftermath of last week's developments on equity line financing, we have updated our model. The massive dilution resulted in a 3x increase in the number of outstanding shares. We are expecting the financing woes to continue into next year, and have hence downgraded our target price. CHANGE IN EPS 2022 : € (0.01) vs (0.02) ns 2023 : € (0.01) vs (0.03) ns The dilution as a resul
In a recent round of equity line financing with convertible bonds, Dolfines was able to bring €4,135k to finance a new acquisition, pay debts and invest in research and development projects. But this came at a grave cost for the shareholders as the share price nose-dived. At this point, the company and the shareholders could only hope for this precarious form of financing to do its job and facilitate cash generation from investments.
Revenue stood at €4.3m in H1, confirming the positive momentum communicated in Q1. The Oil & Gas activities recovered sharply with the high oil price, while the strong growth continued at 8.2 France. The prospects also look good for H2, with drilling activity remaining elevated and with the workforce growing in Renewable energies. Overall, a positive update, which will help to support the stock price.
The strategy update was in line with the recent communications from the company, but provided more details ahead of the capital increase. While the oil & gas activities continue to recover, the priority remains on renewables (both inorganic and organic). A large share of the proceeds will fund acquisitions, with one soon to be announced in renewables services. Furthermore, the company is aiming to break-even at operating cash flow level by the end of the year.
TARGET CHANGE CHANGE IN EPS 2022 : € (0.02) vs (0.02) ns 2023 : € (0.03) vs (0.03) ns We have updated our model with the integration of the FY21 results and net loss of €1.55m. Estimates for FY22/FY23 are unchanged. CHANGE IN NAV € 0.83 vs 1.01 -17.0% Following the FY21 results, we have added a €4m capital increase, at a subscription price of €0.30 per share, leading to the creation of 13.3m shares. This represents a c. 30% discount on the 29/04/2022 closing price (day of the annou
The FY21 results came in below our expectations as Covid-19 dragged on mobility thus limiting oil & gas activities, although the strong start to the year confirms that the recovery is ongoing. As investments ramp up, the company has announced a c. €4m recap, split between debt conversion and an equity increase. The latter should be enough to sustain research & development activities in renewables for both the new floater and the telescopic arm for offshore wind inspection.
EPS CHANGE CHANGE IN EPS 2021 : € (0.06) vs (0.06) ns 2022 : € (0.02) vs (0.03) ns The company has published a positive release, with a strong January and February in inspection and audit (Factorig). We are thus slightly increasing our estimates for Factorig, to €3m of revenue for FY22 vs €2.5m previously, partly offset by lower estimates in Services, where we now forecast revenue of €1.5m vs €1.7m previously.
Research Tree provides access to ongoing research coverage, media content and regulatory news on Dolfines SA. We currently have 50 research reports from 1 professional analysts.
Tlou has released its Q4 update, reporting ongoing progress during recent months on its Lesedi CBM gas-to-power project in Botswana, with first electricity sales continuing to be targeted for 2024.
Companies: Tlou Energy Ltd
Zeus Capital
AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C; target of A$0.75 per share: Diversified and high impact newsflow over the balance of 2024 – ADX has confirmed a very busy programme of activity from September. The overall unrisked value of the programme is ~A$1.70 per share, which represents 17x the current share price. In early September, ADX will drill the Anshof-2A side track. The well is expected to intersect thick Eocene reservoirs similar to that encountere
Companies: EQNR ENI GPRK ADX KAR WDS GALP REP REP EOG PANR TRIN ZPHR CHAR TTE ENI EQNR VAR ATOM GALP TCF
Auctus Advisors
◆ Juggernaut Exploration Ltd. (TSXV: JUGR) owns three highly prospective projects within, and close to, the Golden Triangle in NW BC, a Tier 1 region known for significant discoveries and developments. ◆ Each project is known to host high-grade gold-rich polymetallic discoveries that deserve additional exploration and resource assessment. ◆ The Company is supported by a well-respected fund group Crescat Capital that holds just under 20% of the share capital. ◆ The Company raised C$4.8 million
Companies: Juggernaut Exploration Ltd
Couloir Capital
Companies: 88 Energy Limited (88E:LON)Brighton Pier Group Plc (PIER:LON)
Cavendish
Companies: Gemfields Group Limited
Panmure Liberum
Edison Investment Research is terminating coverage on Cadence Minerals (KDNC). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Companies: Cadence Minerals PLC
Edison
Prospex Energy (PXEN LN) has announced a ten year extension of the licence concessions for its Spanish El Romeral project where the company produces natural gas and converts it to electricity. The extension was for the maximum allowable ten years to 2034 and can be extended to 2044. We note the Spanish Government’s quote highlighting the benefits of the extension and its securing electricity supply to the grid for the long-term. This follows the declaration in 2023 of the plant as a Public Utili
Companies: Prospex Energy Plc
VSA Capital
i3 Energy is an AIM and TSX-listed oil and gas company with a diversified 20kboe/d production base onshore Canada, which offers UK investors attractive exposure to North American E&P themes. The Company's production growth strategy is sensibly hedged to pivot between acquiring producing assets when commodity prices are low and to invest in its low-risk drilling inventory when prices are high.
Companies: i3 Energy Plc
SP Angel
Joiners: No joiners today. Leavers: Medica Group plc has left the Premium Segment of the Main Market. What’s cooking in the IPO kitchen?** Blackpoint Biotech plc, a medical cannabinoids company established to fulfil gaps in the medical cannabis market by creating products that provide fast onset of action and accurate dosing, intends to join intends to join the Access Segment of the AQSE Growth Market. Expected Admission 20 July 2023. Metals One Plc, a company focusing on acquiring natural resou
Companies: TNTAF CRL ITM VAST CMX RENX MAFL HE1
Hybridan
i3 Energy announced that its 2024 guidance consists of expectations to drill 10.5 net wells (7.6 net wells in Central Alberta, 1.9 net wells in Simonette and 1.0 net wells in the Clearwater play) with 85% of capex allocated to the second half of the year. Total capex expenditure for the year is guided at $US 50.9m. The company indicated that it intends to commence pad drilling of its Montney acreage in Q1 2025 and we perceive the company is bulking up for that significant growth opportunity for
I3E is a UK and Canada listed E&P company, with a significant producing asset position onshore Canada in Alberta.
Union Jack has released the successful initial results of its Andrews 2-17 well (Union Jack 45%), which has been drilled on the company’s West Bowlegs asset in Oklahoma.
Companies: Union Jack Oil Plc
Panthera Resources (PAT.L) recently (25/08/23) made an important announcement that could potentially unlock the value of its world-class Bhukia gold project in Rajasthan, north-west India. Non-recourse litigation financing of US$13.6m has been secured from LCM Funding SG Pty Ltd, a subsidiary of Litigation Capital Management Ltd (LITL: AIM), a leading global disputes funder, to pursue a claim against the Republic of India for a breach of treaty obligations under the 1999 Agreement between Austra
Companies: Panthera Resources Plc
Allenby Capital
Serica Energy is a ~US800 mm market cap company with >40 mboe/d production and 140 mmboe of 2P reserves in the UK North Sea. The investment case is about value and generous shareholder distributions. The strategy is to maximize the value of two key producing hubs, depending on the UK’s tax policy, to develop a third one at Buchan Horst and to grow via M&A. Over the last 2 years, the share price has been negatively impacted by the reduction in UK gas prices and fiscal uncertainty. Serica’s divide
Companies: Serica Energy PLC
Condor Energies (CDR CN)C: Signing first LNG framework agreement in Kazakhstan – Condor has signed a first LNG Framework Agreement for the utilization of LNG to fuel Kazakhstan’s rail locomotives. The agreement was also signed by Kazakhstan Temir Zholy (KTZ), the national railway operator of Kazakhstan and Wabtec Corporation, a U.S. based locomotive manufacturer with existing facilities in Kazakhstan. KTZ and Wabtec previously signed a memorandum of understanding which includes modernization wor
Companies: TCFF OKEA MAHAA TNZ MCF ENW PHAR NOG BWEFF MAHAA OKEA EGY